US Patent Issued to Hoffmann-La Roche on June 23 for "Means and methods for assessing Huntington's disease of the pre-manifest stage" (Swiss Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,661,055, issued on June 23, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Means and methods for assessing Huntington's disease of the pre-manifest stage" was invented by Michael Lindemann (Basel, Switzerland), Florian Lipsmeier (Basel, Switzerland) and Cedric Andre Marie Vincent Geoffrey Simillion (Basel, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the field of diagnostics. Specifically, it relates to a method for assessing Huntington's disease of the pre-manifest stage in a subject comprising the steps of determining at least one performance parameter from a dataset of fine motoric measure...